世界の皮膚細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cutaneous Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4076 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、皮膚細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・皮膚細胞リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・皮膚細胞リンパ腫治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、モノクローナル抗体療法、その他） ・皮膚細胞リンパ腫治療の用途別市場規模と予測2016-2027（病院、診療所、外来外科センター、その他） ・皮膚細胞リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚細胞リンパ腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚細胞リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚細胞リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚細胞リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Novartis、Medivir AB、Seattle Genetics、Soligenix、Merck、Bristol-Myers Squibb、Genmab AS、Pfizer、AstraZeneca、Gilead Sciences、Epizyme、NanoString Technologies、Amgen、Johnson & Johnson） ・結論

Market Analysis and Insights: Global Cutaneous Cell Lymphoma Treatment Market
The global Cutaneous Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cutaneous Cell Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cutaneous Cell Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cutaneous Cell Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cutaneous Cell Lymphoma Treatment market.

Global Cutaneous Cell Lymphoma Treatment Scope and Market Size
Cutaneous Cell Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cutaneous Cell Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Monoclonal Antibodies Therapy
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Novartis
Medivir AB
Seattle Genetics
Soligenix
Merck
Bristol-Myers Squibb
Genmab AS
Pfizer
AstraZeneca
Gilead Sciences
Epizyme
NanoString Technologies
Amgen
Johnson & Johnson

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Cell Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Monoclonal Antibodies Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cutaneous Cell Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cutaneous Cell Lymphoma Treatment Market Perspective (2016-2027)
2.2 Cutaneous Cell Lymphoma Treatment Growth Trends by Regions
2.2.1 Cutaneous Cell Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cutaneous Cell Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cutaneous Cell Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cutaneous Cell Lymphoma Treatment Industry Dynamic
2.3.1 Cutaneous Cell Lymphoma Treatment Market Trends
2.3.2 Cutaneous Cell Lymphoma Treatment Market Drivers
2.3.3 Cutaneous Cell Lymphoma Treatment Market Challenges
2.3.4 Cutaneous Cell Lymphoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Cell Lymphoma Treatment Players by Revenue
3.1.1 Global Top Cutaneous Cell Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Cutaneous Cell Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cutaneous Cell Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Cell Lymphoma Treatment Revenue
3.4 Global Cutaneous Cell Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Cutaneous Cell Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Cell Lymphoma Treatment Revenue in 2020
3.5 Cutaneous Cell Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Cutaneous Cell Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Cutaneous Cell Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cutaneous Cell Lymphoma Treatment Breakdown Data by Type
4.1 Global Cutaneous Cell Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cutaneous Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027)

5 Cutaneous Cell Lymphoma Treatment Breakdown Data by Application
5.1 Global Cutaneous Cell Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cutaneous Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cutaneous Cell Lymphoma Treatment Market Size (2016-2027)
6.2 North America Cutaneous Cell Lymphoma Treatment Market Size by Type
6.2.1 North America Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Cutaneous Cell Lymphoma Treatment Market Size by Application
6.3.1 North America Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Cutaneous Cell Lymphoma Treatment Market Size by Country
6.4.1 North America Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cutaneous Cell Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Cutaneous Cell Lymphoma Treatment Market Size by Type
7.2.1 Europe Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Cutaneous Cell Lymphoma Treatment Market Size by Application
7.3.1 Europe Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Cutaneous Cell Lymphoma Treatment Market Size by Country
7.4.1 Europe Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cutaneous Cell Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Type
9.2.1 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Application
9.3.1 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Country
9.4.1 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cutaneous Cell Lymphoma Treatment Introduction
11.1.4 Roche Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Cutaneous Cell Lymphoma Treatment Introduction
11.2.4 Novartis Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Medivir AB
11.3.1 Medivir AB Company Details
11.3.2 Medivir AB Business Overview
11.3.3 Medivir AB Cutaneous Cell Lymphoma Treatment Introduction
11.3.4 Medivir AB Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.3.5 Medivir AB Recent Development
11.4 Seattle Genetics
11.4.1 Seattle Genetics Company Details
11.4.2 Seattle Genetics Business Overview
11.4.3 Seattle Genetics Cutaneous Cell Lymphoma Treatment Introduction
11.4.4 Seattle Genetics Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.4.5 Seattle Genetics Recent Development
11.5 Soligenix
11.5.1 Soligenix Company Details
11.5.2 Soligenix Business Overview
11.5.3 Soligenix Cutaneous Cell Lymphoma Treatment Introduction
11.5.4 Soligenix Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.5.5 Soligenix Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Cutaneous Cell Lymphoma Treatment Introduction
11.6.4 Merck Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Cutaneous Cell Lymphoma Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Genmab AS
11.8.1 Genmab AS Company Details
11.8.2 Genmab AS Business Overview
11.8.3 Genmab AS Cutaneous Cell Lymphoma Treatment Introduction
11.8.4 Genmab AS Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.8.5 Genmab AS Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Cutaneous Cell Lymphoma Treatment Introduction
11.9.4 Pfizer Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Cutaneous Cell Lymphoma Treatment Introduction
11.10.4 AstraZeneca Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Cutaneous Cell Lymphoma Treatment Introduction
11.11.4 Gilead Sciences Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.11.5 Gilead Sciences Recent Development
11.12 Epizyme
11.12.1 Epizyme Company Details
11.12.2 Epizyme Business Overview
11.12.3 Epizyme Cutaneous Cell Lymphoma Treatment Introduction
11.12.4 Epizyme Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.12.5 Epizyme Recent Development
11.13 NanoString Technologies
11.13.1 NanoString Technologies Company Details
11.13.2 NanoString Technologies Business Overview
11.13.3 NanoString Technologies Cutaneous Cell Lymphoma Treatment Introduction
11.13.4 NanoString Technologies Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.13.5 NanoString Technologies Recent Development
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Cutaneous Cell Lymphoma Treatment Introduction
11.14.4 Amgen Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.14.5 Amgen Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Cutaneous Cell Lymphoma Treatment Introduction
11.15.4 Johnson & Johnson Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
11.15.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cutaneous Cell Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Monoclonal Antibodies Therapy
Table 5. Key Players of Others
Table 6. Global Cutaneous Cell Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cutaneous Cell Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cutaneous Cell Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cutaneous Cell Lymphoma Treatment Market Share by Regions (2016-2021)
Table 10. Global Cutaneous Cell Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cutaneous Cell Lymphoma Treatment Market Share by Regions (2022-2027)
Table 12. Cutaneous Cell Lymphoma Treatment Market Trends
Table 13. Cutaneous Cell Lymphoma Treatment Market Drivers
Table 14. Cutaneous Cell Lymphoma Treatment Market Challenges
Table 15. Cutaneous Cell Lymphoma Treatment Market Restraints
Table 16. Global Cutaneous Cell Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cutaneous Cell Lymphoma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Cutaneous Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Cell Lymphoma Treatment as of 2020)
Table 19. Ranking of Global Top Cutaneous Cell Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cutaneous Cell Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cutaneous Cell Lymphoma Treatment Product Solution and Service
Table 23. Date of Enter into Cutaneous Cell Lymphoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cutaneous Cell Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Cutaneous Cell Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cutaneous Cell Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cutaneous Cell Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cutaneous Cell Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Cutaneous Cell Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cutaneous Cell Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Cutaneous Cell Lymphoma Treatment Product
Table 66. Roche Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Cutaneous Cell Lymphoma Treatment Product
Table 71. Novartis Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Medivir AB Company Details
Table 74. Medivir AB Business Overview
Table 75. Medivir AB Cutaneous Cell Lymphoma Treatment Product
Table 76. Medivir AB Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 77. Medivir AB Recent Development
Table 78. Seattle Genetics Company Details
Table 79. Seattle Genetics Business Overview
Table 80. Seattle Genetics Cutaneous Cell Lymphoma Treatment Product
Table 81. Seattle Genetics Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 82. Seattle Genetics Recent Development
Table 83. Soligenix Company Details
Table 84. Soligenix Business Overview
Table 85. Soligenix Cutaneous Cell Lymphoma Treatment Product
Table 86. Soligenix Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 87. Soligenix Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Cutaneous Cell Lymphoma Treatment Product
Table 91. Merck Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Bristol-Myers Squibb Company Details
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Cutaneous Cell Lymphoma Treatment Product
Table 96. Bristol-Myers Squibb Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Genmab AS Company Details
Table 99. Genmab AS Business Overview
Table 100. Genmab AS Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 101. Genmab AS Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Cutaneous Cell Lymphoma Treatment Product
Table 105. Pfizer Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Cutaneous Cell Lymphoma Treatment Product
Table 110. AstraZeneca Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 111. AstraZeneca Recent Development
Table 112. Gilead Sciences Company Details
Table 113. Gilead Sciences Business Overview
Table 114. Gilead Sciences Cutaneous Cell Lymphoma Treatment Product
Table 115. Gilead Sciences Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 116. Gilead Sciences Recent Development
Table 117. Epizyme Company Details
Table 118. Epizyme Business Overview
Table 119. Epizyme Cutaneous Cell Lymphoma Treatment Product
Table 120. Epizyme Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 121. Epizyme Recent Development
Table 122. NanoString Technologies Company Details
Table 123. NanoString Technologies Business Overview
Table 124. NanoString Technologies Cutaneous Cell Lymphoma Treatment Product
Table 125. NanoString Technologies Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 126. NanoString Technologies Recent Development
Table 127. Amgen Company Details
Table 128. Amgen Business Overview
Table 129. Amgen Cutaneous Cell Lymphoma Treatment Product
Table 130. Amgen Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 131. Amgen Recent Development
Table 132. Johnson & Johnson Company Details
Table 133. Johnson & Johnson Business Overview
Table 134. Johnson & Johnson Cutaneous Cell Lymphoma Treatment Product
Table 135. Johnson & Johnson Revenue in Cutaneous Cell Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 136. Johnson & Johnson Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Cell Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Monoclonal Antibodies Therapy Features
Figure 5. Others Features
Figure 6. Global Cutaneous Cell Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Cutaneous Cell Lymphoma Treatment Report Years Considered
Figure 12. Global Cutaneous Cell Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cutaneous Cell Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cutaneous Cell Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Cutaneous Cell Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 16. Global Cutaneous Cell Lymphoma Treatment Market Share by Players in 2020
Figure 17. Global Top Cutaneous Cell Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Cell Lymphoma Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cutaneous Cell Lymphoma Treatment Revenue in 2020
Figure 19. Global Cutaneous Cell Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Cutaneous Cell Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cutaneous Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 23. North America Cutaneous Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 24. North America Cutaneous Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 25. United States Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cutaneous Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 29. Europe Cutaneous Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 30. Europe Cutaneous Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 31. Germany Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cutaneous Cell Lymphoma Treatment Market Share by Region (2016-2027)
Figure 41. China Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cutaneous Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Cutaneous Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Cutaneous Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cutaneous Cell Lymphoma Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cutaneous Cell Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 62. Medivir AB Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 63. Seattle Genetics Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 64. Soligenix Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 67. Genmab AS Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 71. Epizyme Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 72. NanoString Technologies Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 73. Amgen Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 74. Johnson & Johnson Revenue Growth Rate in Cutaneous Cell Lymphoma Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---